Literature DB >> 32880536

South Africa's coronavirus testing strategy is broken and not fit for purpose: It's time for a change.

M Mendelson1, S Madhi.   

Abstract

Mesh:

Year:  2020        PMID: 32880536

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  5 in total

1.  Implementation of Antibody Rapid Diagnostic Testing versus Real-Time Reverse Transcription-PCR Sample Pooling in the Screening of COVID-19: a Case of Different Testing Strategies in Africa.

Authors:  Tinashe K Nyazika; Rabelani Kaela; Mathias Mugoni; Kudakwashe Musomekwa; Eric Kyei-Baafour; Simbarashe Chiwanda; Prichard T Mapondera; Tatenda S Makawa; Elliot M Sithole; George Mavunganidze; Justen Manasa; Kondwani C Jambo; Cuthbert Musarurwa
Journal:  mSphere       Date:  2020-07-29       Impact factor: 4.389

2.  Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test.

Authors:  Terezinha Marta Pereira Pinto Castineiras; Érica Ramos Dos Santos Nascimento; Débora Souza Faffe; Rafael Mello Galliez; Diana Mariani; Isabela de Carvalho Leitão; Mayla Gabryele Miranda de Melo; Orlando Costa Ferreira; Amilcar Tanuri
Journal:  Braz J Infect Dis       Date:  2021-10-12       Impact factor: 3.257

3.  Cardiovascular care in sub-Saharan Africa during the COVID-19 crisis: lessons from the global experience.

Authors:  Kishal Lukhna; Blanche Cupido; Jens Hitzeroth; Ashley Chin; Mpiko Ntsekhe
Journal:  Cardiovasc J Afr       Date:  2020 May/Jun       Impact factor: 1.167

Review 4.  Implementing COVID-19 (SARS-CoV-2) Rapid Diagnostic Tests in Sub-Saharan Africa: A Review.

Authors:  Jan Jacobs; Vera Kühne; Octavie Lunguya; Dissou Affolabi; Liselotte Hardy; Olivier Vandenberg
Journal:  Front Med (Lausanne)       Date:  2020-10-30

Review 5.  Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa.

Authors:  Emmanuel Margolin; Wendy A Burgers; Edward D Sturrock; Marc Mendelson; Rosamund Chapman; Nicola Douglass; Anna-Lise Williamson; Edward P Rybicki
Journal:  Nat Rev Microbiol       Date:  2020-09-10       Impact factor: 60.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.